Oseltamivir
Treatment for Lower respiratory infections
Typical Dosage: 75 mg twice daily
Effectiveness
75%
Safety Score
65%
Clinical Trials
4
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
75 mg twice daily
Time to Effect
1-2 days
Treatment Duration
5 days
Evidence Quality
HIGHNumber Needed to Treat (NNT)
25(Treat 25 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$150
Side Effect Mgmt:$5
Total Annual:$230
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$75,000/QALY
QALYs Gained
0.03
Outcome-Based Costs
Cost per Responder
$353.85
Cost per Remission
$920
Comparison vs Supportive Care
Cost Difference
+$75/year
More expensive
QALY Difference
+0.03 QALYs
Better outcomes
Dominance
No dominance
Oseltamivir Outcomes
for Lower respiratory infections
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+65%
Remission Rate
+25%
Common Side Effects
Nausea/vomiting
+12.5%
Headache
+2.5%
Neuropsychiatric events
+0.05%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Oseltamivir in Lower respiratory infections
Oseltamivir Randomised Controlled Efficacy Trial
NCT00707941COMPLETEDPHASE3
1.19K participants
INTERVENTIONAL
Dhaka, Bangladesh
Started: May 1, 2008